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Background: There is as yet limited evidence about fertility-sparing surgery for early ovarian cancer (EOC) carried
out laparoscopically. We sought to analyze recurrence patterns and fertility outcome in a cohort of ovarian cancer
patients who underwent fertility-saving laparoscopic surgical staging.
Methods: We conducted a retrospective analysis of prospectively collected data on all patients undergoing
fertility-sparing laparoscopic staging procedures for presumed EOC at a single gynecologic oncology service.
Oncologic safety and reproductive outcome were the main outcome measures. The pertinent literature is reviewed.
Results: The study cohort consisted of 12 women. Cases included 5 invasive epithelial tumors and 7 nonepithelial
tumors. The disease was reclassified to a higher stage in one woman. After a median follow up period of
38 months (range: 14–108), the overall survival was 100% and recurrence-free survival 90.9%. Five (100%) of patients
who attempted pregnancy conceived spontaneously. Three of them had uneventful term pregnancy delivering
healthy babies. The literature search yielded 62 cases of laparoscopic fertility conserving surgery for ovarian cancer.
There were 4 (6.2%) recurrences. Cumulative pregnancy and live birth rate were not estimable as earlier publications
lack essential data.
Conclusions: Laparoscopic staging may represent a viable option for premenopausal women seeking fertility
preservation in the setting of early ovarian cancer. More research is needed to determine whether laparoscopy may
offer reproductive benefits to this particular population.
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While ovarian cancer is predominantly a disease of older,
post-menopausal women, it is estimated that in western
countries approximately 12% of cases will be diagnosed
in women younger than 45 years of age [1]. Each year in
Europe and in the US over 10,000 new cases of malig-
nant ovarian neoplasms occur in women of the repro-
ductive age group [1,2].
In today’s society, women often postpone childbearing
for cultural, financial and professional reasons, and in
their late 30s to early 40s are attempting to get pregnant
for the first time. As a result, the demand for fertility-
sparing options grows among young women with cancer,* Correspondence: antonellacromi@libero.it
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unless otherwise stated.including ovarian cancer, which is still the deadliest of
all gynecologic cancers. Younger women are more likely
to be initially diagnosed with stage I disease [3], for
which 5-year survival rates approach 90% [1], and gyne-
cologic oncologists are increasingly facing the challenge
of how to manage early-stage ovarian carcinoma in pre-
menopausal women who desire future fertility.
Accumulated experience indicates that the oncologic
results following conservative treatment with retention
of the uterus and contralateral ovary are reassuring and
similar to standard staging, and shows acceptable re-
currence rates [4-6]. However, there are no randomized
trials comparing the traditional comprehensive staging
to fertility-sparing surgery and it is unlikely that such
a trial will ever be conducted. Studies dealing with
fertility-sparing treatment in the last 20 years are oftentd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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or unknown follow-up periods, lack of stratification by
histologic type and grading [5,6]. Evidence is even more
scant and problematic for fertility-sparing procedures
carried out laparoscopically [7-12]. Unlike what occurred
with endometrial and cervical cancer, the widespread
acceptance and adoption of laparoscopic staging of early
ovarian cancer (EOC) has been much slower and min-
imal access surgery in this context is still regarded as
investigational, despite initial recognition of its role by
leading oncology societies [13,14].
The advantages of a laparoscopic approach, including
less tissue and organ handling, lower bleeding, and
lower contamination with foreign bodies than open sur-
gery, by reducing the potential for adhesions may be
particularly beneficial in women wishing to preserve
their fertility. Moreover, avoiding a midline abdominal
scar from xiphoid to pubis, which can alter one’s per-
ception of body image with a negative impact on self-
esteem or self-confidence, may be especially important
for young EOC patient [15,16].
As surgical pioneers began to accumulate sufficient data
in support of minimally invasive techniques for EOC, co-
hort studies are emerging in which a few conservatively
treated patients have been included [7-12,17-22]. How-
ever, absence of oncologic detriment and fertility outcome
cannot be inferred due to small numbers, failure to
analyze treatment effects within this subgroup of patients,
commixture of low malignant potential and invasive
tumors.
In this article, we report our experience with laparo-
scopic treatment of premenopausal women seeking fertility
preservation in the setting of a unilateral ovary-confined
ovarian cancer and we review currently available data re-
garding the results of fertility-sparing minimally invasive
surgery for EOC.
Methods
We have collected prospective data on all patients
undergoing fertility-sparing laparoscopic staging pro-
cedures for presumed early-stage ovarian cancers from
December 2004 to December 2012 at the Gynecologic
Oncology Division of University of Insubria, Varese,
Italy.
Laparoscopic approach for the staging of early stage
ovarian cancer was introduced at our Department in
January 2003. Once laparoscopic techniques have been
incorporated in the management of apparent stage I
ovarian cancers, from that moment onwards this ap-
proach was offered to each patient presenting with that
condition, unless specific contraindications existed, such
as a documented significant cardiopulmonary disease.
No patient was refused laparoscopic surgery for reasons
of tumor size, obesity, prior surgical history, anticipateddifficulty of resection. In women less than 40 years of
age who have not yet completed childbearing, the option
of conservative treatment with retention of the uterus
and contralateral ovary has been offered. A complete ob-
stetric and gynecological history was obtained to identify
patients with underlying potential infertility problems.
Infertility work-up to document fertility potential was
not required prior to the procedure. Women who were
in the late 30’s were made aware that their fertility po-
tential was obviously less.
Fertility-sparing laparoscopic surgery was offered as an
alternative therapy with modifications of standard treat-
ment, according to institutional guidelines that dictate the
required elements of informed consent. We did not per-
form such procedures as a part of a formalized research
program. The specific consent form is aimed at maxi-
mizing patient understanding of the non-standard nature
of the fertility preserving treatment, and forces patients to
weigh the risks and benefits associated with each treat-
ment option. A very thorough and extensive counseling,
highlighting the risks potentially inherent in non-standard
care, has been given to the patient and partner, and imme-
diate family members before the decision to proceed with
a fertility sparing surgery. At our institution research ac-
tivities involving the collection or study of existing data
are exempt from the requirement of IRB approval.
For the purposes of this study, early ovarian cancer
(EOC) was defined as an ovarian tumor grossly limited to
one ovary, with no evidence of intraperitoneal disease.
During the initial laparoscopic examination, patients who
were found to have the disease beyond the ovary were ex-
cluded. The procedures were performed by surgeons with
extensive training and experience in gynecologic oncology
and in advanced minimally invasive surgery. Detailed de-
scription of surgical technique used for laparoscopic sta-
ging of EOC has been reported elsewhere [23].
The department’s contemporaneously collected sur-
gical database was reviewed. All histologic types of ad-
nexal cancers, including stromal and germ cell tumors
were included. Intraoperative details and post-operative
complications were prospectively collected within the
surgical database at the end of the procedure and at
discharge from hospital. The database is updated on a
regular basis and contains detailed information on post-
treatment follow-up, including reproductive outcomes
data. Intraoperative mass rupture was defined as any
rupture, intentional or unintentional, that resulted in
spill of cyst contents into the peritoneal cavity. Opera-
tive times were defined as ‘skin-to-skin’ time. Any late
(>30 days) surgical complications and follow-up infor-
mation are systematically added to the database by the
reviewing clinician. The first 7 patients of the study co-
hort had been included in previously published studies
on laparoscopic staging of EOC [17,23].








Undifferentiated carcinoma 1 (8.3%)
Dysgerminoma 2 (16.7%)
Granulosa cell tumor 2 (16.7%)
Immature teratoma 1 (8.3%)





Rare histologic types (grading not performed) 5 (41.7%)
Final stage
I a 5 (41.7%)
I c 5 (41.7%)
II b 1 (8.3%)
III c 1 (8.3%)
Data are expressed as number (%).
Table 2 Intra- and postoperative details
Study cohort
(N = 12)
Operative time (min) 320 (120–450)
Blood loss (mL) 100 (10–500)
Blood transfusions 0
Pelvic lymphnodes (n) 21 (16–39)
Paraaortic lymphnodes (n) 7 (2–16)
Intraoperative complications 0
Postoperative complications 1 (8.3%)
Hospital stay (days) 3 (1–8)
Data are expressed as median (range) or number (%).
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A comprehensive PUBMED literature search was con-
ducted searching from January 1995 to August 2013 and
including only English language citations. The search
headings “ovarian cancer”, “fertility-sparing”, and “laparos-
copy” were used. Included were reports which addressed
specifically laparoscopic fertility-sparing staging at first
diagnosis of invasive ovarian or fallopian tube cancer.
We excluded series including borderline tumors if it
was not possible to discriminate data related to women
with invasive cancer, as the surgical aim for staging dif-
fered from that with invasive disease and follow up data
would be skewed. Also excluded were series in which
patients undergoing fertility-sparing surgery were non
separable from other laparoscopically managed EOC
patients.
Results
A total of 12 patients underwent fertility-conserving la-
paroscopic surgery for presumed stage I ovarian cancer.
Median age of the patients was 31 (range: 13–39) years,
with 7/12 (58.3%) patients who were referred for re-
staging following cystectomy or salpingo-oophorectomy
with findings of invasive disease on final pathology and
5/12 (41.7%) women presenting with adnexal masses
suspicious for malignancy. Cases included 5/12 (41.7%)
invasive epithelial tumors and 7/12 (58.3%) nonepithelial
tumors. Tumor characteristics are outlined in Table 1.
Intra- and post-operative details are provided in Table 2.
No conversion to laparotomy and no intraoperative com-
plication occurred. Five (41.7%) patients experienced in-
traoperative cyst rupture. A 23-year old girl developed one
month after surgery a pleural empyema that resolved
with appropriate antibiotic and did not result in patient
morbidity.
Based on final pathology, one (1/12, 8.3%) patient was
upstaged to stage IIIC. Histology revealed an undifferen-
tiated carcinoma and upstaging was due to para-aortic
lymph node involvement. After thorough counseling the
patient underwent a repeat operation to complete sta-
ging with hysterectomy and contralateral oophorectomy.
She received first line chemotherapy with a combination
of carboplatin and pacitaxel and a second-line regimen
with doxorubicin due to evidence of progressive disease.
She died of disease 11 months after diagnosis. This pa-
tient has been excluded from any subsequent analyses of
outcome data.
Two patients with endometroid carcinoma and one
with mucinous histology were given adjuvant chemo-
therapy with single agent carboplatin (AUC 6 mg/mL
per min) for six cycles. One woman with a G2 serous
carcinoma received a combination of carboplatin (AUC
6 mg/mL per min) and Paclitaxel (175 mg/m2) for six
cycles.Two women with struma ovarii were managed postop-
eratively with total thyroidectomy and radioactive I-131
ablation. Menstrual function was preserved in all patients.
Five of 5 (100%) patients who attempted pregnancy con-
ceived. One had a miscarriage at 12 gestational weeks; a
20-year old girl opted for termination of pregnancy due to
social reasons; 3/5 (60%) patients had uncomplicated term
pregnancies, two of which after receipt of chemotherapy,
with no congenital anomalies in the offspring. None re-
ceived an infertility treatment before pregnancy. A patient
with serous epithelial ovarian cancer who achieved a term
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staging but she opted to postpone the definite treatment
after a second pregnancy will be obtained.
One patient with a granulosa cell tumor, who achieved
pregnancy one year after primary procedure, developed
pelvic peritoneal recurrence 27 months after diagnosis.
She underwent recurrence resection, completion of sta-
ging, and chemotherapy with cisplatin/etoposide/bleo-
mycin. She is currently disease free after 5-year follow-up.
After a median follow up period of 38 months since
diagnosis (range: 14–108), the overall survival in our co-
hort was 100% and recurrence-free survival 90.9%.Literature review
The PUBMED search identified 354 citations; 334 were
excluded and 20 retrieved for detailed review (Figure 1).
Following exclusions, see Figure 1 for reasons, there were
five identified papers reporting oncologic and/or repro-
ductive outcomes after fertility-sparing laparoscopy for
ovarian cancer (Table 3). All previous reports are single
institution case reports of, at most 17 women. Overall,
there were 4/62 (6.2%) recurrences. Cumulative pregnancy
and live birth rate were not estimable as earlier publica-
tions lack essential data.Discussion
The current study and our literature review revealed a
small but growing body of evidence that fertility-saving
laparoscopic surgical staging can be offered to selectedCitations identified in MEDLINE using 
Studies retrieved for more detailed 
evaluation (n=20)
Studies included in the review (n=5)
Figure 1 Flowchart that summarizes the process and results of our litwomen with EOC as a viable fertility-sparing alternative
to traditional laparotomy.
Ovarian cancer is the most deadly of all malignancies of
the female genital tract. In the past, survival, the primary
goal of cancer treatment, tended to overshadow survivor-
ship considerations. However, there has been a clear im-
provement in five-year survival for stage I patients since
the late 1980s [24], and therefore, issues affecting long-
term cancer survivors has become more widely recognized.
In recent decades there has been an increased emphasis on
tailoring treatment to provide fertility-sparing options
without compromising oncologic outcomes in women who
present with malignancy that appears confined to the
ovary. However, fertility-sparing surgery results in a deli-
berately incomplete staging and therefore poses a major
clinical challenge since this may potentially increase the
risk of recurrence. In a series including 118 women with
EOC that appeared to have disease confined to one ovary,
after full staging the contralateral ovary had microscopic
disease without spread elsewhere in 2.5% of cases [25].
Experience with open surgery indicates that the onco-
logic outcomes following fertility-sparing procedures are
similar to those with complete surgical staging. A recent
review of the published literature identified 15 studies
with a total of 918 young women with EOC who under-
went fertility-sparing surgery [6]. They had a 11.9% chance
of recurrence and 5.2% chance of death from disease,
which is comparable to fully-staged historical controls
[26,27]. Combining the published literature, out of a total
918 women, there were 242 pregnancies from 177 women,References irrelevant to study purpose after 
scanning title and abstract (n=334)
Excluded (n=15)
Series including laparoscopic complete 
staging only  (n=7)
Patients with borderline tumors non 
separable from those with invasive 
cancer (n=2)
Patients undergoing fertility-sparing 
surgery non separable from other 
laparoscopically managed EOC patients 
who had complete staging (n=3)
Patients undergoing laparoscopic 
staging non separable from those 
undergoing open surgery (n=3)
erature review.
Table 3 Laparoscopic fertility-sparing staging for presumed early stage adnexal cancers; systematic review of literature
and current data




Leblanc [7] Prospective 9 * 0 3/not reported *
Muzii [9] Prospective 15 11 1 3/not reported *
Nezhat [10] Retrospective 5 5 1 * *
Cheng [11] Retrospective 17 17 1 5/8 61 (17–115)
Brockbank [12] Prospective 16 * 1 * *
Current study Prospective 11† 4 1 5/5 28 (7.3–101)
Total 73 - 5 (6.8%) - -
*Not possible to discriminate data related to women with EOC undergoing fertility sparing procedures from those who had comprehensive staging.
†One patient upstaged after intial fertility-sparing surgery has been excluded as she ultimately underwent a comprehensive staging.
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10%. Although these results are encouraging, series of
more than 20 patients do show recurrent disease presen-
ting confined to the preserved ovary in 4.8% of cases [4].
Moreover, available outcome data should be viewed in light
of some limitations. First, there is a lack of prospective
data. Second, it is not known whether the histological sub-
type, breast cancer gene status or other factors influence
the prognosis for these patients with early stage disease
when treated conservatively. Third, the appropriateness of
offering fertility sparing procedures for grade 3 or stage IC
tumors, or in selected cases with disease extended beyond
the ovaries [28] is highly debated. Finally, in several series
pregnancy rates are not calculated using women attemp-
ting to conceive as the denominator [29,30].
The type of surgical approach is a further variable to be
taken into account in an already-complex field. A limited
but expanding body of literature suggests that laparoscopic
comprehensive staging of apparent EOC is technically
feasible and can provide equivalent surgical assessment
when compared with laparotomy. Minimally invasive sur-
gery offers several established advantages to the cancer pa-
tient needing surgery: less bleeding, less trauma, less risk
of incisional hernias and postoperative infection, and
quicker, less painful recovery [31]. Besides these clearly de-
fined advantages, laparoscopic staging may offer repro-
ductive benefits to women seeking fertility preservation in
the setting of ovarian carcinomas grossly confined to one
ovary, but this is not proven. A laparoscopic approach has
been indicated as preferable to laparotomy for fertility-
sparing surgeries due to reduced adhesion formation fol-
lowing laparoscopy and avoidance of laparotomy, known
to decrease fecundity [31]. Postsurgical adhesions may ad-
versely affect fertility by distorting adnexal anatomy and
interfering with gamete and embryo transport. To date, no
comparative studies of laparoscopy vs. open surgery in
women undergoing fertility-saving procedures for a gyne-
cologic cancer have been published, so potential benefitson reproductive function are only inferred from multiple
observations in non-oncological medical fields [32,33].
Furthermore, undefined risks of port site metastasis,
tumor seeding and intraoperative tumor rupture asso-
ciated with laparoscopic staging continues to be debated.
Available data suggest that these risks may not outweigh
the clearly established benefits of a minimally invasive
access in the setting of careful patient selection and pre-
operative assessment. However, the safety issues become
even more crucial in the context of fertility-sparing sur-
gery that results in an intentionally incomplete staging.
Hu et al. in a retrospective series of 94 women who had
fertility-sparing treatment for EOC found that a lapa-
roscopic approach did not affect overall and disease-free
survival [21]. Kajiyama et al. [27] assessed survival after
fertility-sparing surgery separately for women with stage
Ic due to iatrogenic cyst rupture versus Ic due to malig-
nant cells in peritoneal washings or surface involvement.
They found no significant difference in DFS and OS bet-
ween patients with “iatrogenic” stage IC and those with
stage IA, whereas survival outcomes of the patients with
“biologic” IC disease were poorer than those of patients
with stage IA. Notwithstanding the lack of unequivocal
evidence that cyst rupture in patients who would have
been stage IA and who are upgraded to stage IC solely be-
cause of the occurrence of intraoperative rupture worsens
the prognosis, this observation is helpful for the definition
of selection criteria for the optimal candidate for laparo-
scopic fertility-sparing treatment for EOC. Indeed,
whether stage IC tumors are suitable for fertility sparing
surgery is debatable and guidelines diverge in their recom-
mendations. Minimal access surgery is more likely than
laparotomy to result in intentional capsular rupture, since
large tumors often require drainage before removal both
to allow specimen retrieval and to achieve adequate
working space. It is hoped that future data will better ad-
dress whether intentional capsular rupture during surgery
should be distinguished from preoperative spillage of cyst
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of cancer therapy in young women undergoing lapa-
roscopic surgical staging for EOC with fertility-sparing
intent.
There have been few studies performed with the specific
intent of reporting recurrence in patients who underwent
a more conservative, fertility-sparing laparoscopic staging.
In several series [17-22] oncologic outcomes of women
undergoing fertility-sparing surgery are not described sep-
arately from those of the entire cohort, thus preventing
any risk estimate. Given the rarity of early stage adnexal
tumors in reproductive-age women, clinical decisions on
the surgical approach in this population will need to be
made from case series reports, of which this current series
adds to the scant available literature. This study represents
the first attempt to prospectively assess the results
of laparoscopy in this specific group of EOC patients.
Hopefully, as more and more cancer centers offer laparo-
scopic staging of EOC, data of the subpopulation of
women undergoing fertility-sparing surgery will be re-
ported separately.
A significant proportion of patients who do not try to
get pregnant after fertility preserving procedures is a
consistent finding in the published series on this issue
[4]. For those patients with malignant germ cell tumors,
the earlier mean age at time of diagnosis and prediction
of good outcome after fertility preservation, are the most
likely reasons for postponing childbearing. Women elec-
ting not to attempt pregnancy after conservative surgical
management of ovarian carcinomas poses more complex
issues. A strong desire on the part of the patient to re-
tain fertility potential is a crucial point in the selection
of patients for performing fertility sparing procedures.
Young women should be made aware that, although
there is no evidence that currently used fertility pre-
servation options directly compromise the success of
cancer therapy, the conventional accepted treatment re-
mains comprehensive staging. Questions still remain on
the acceptability of conservative options where fertility is
not an immediate concern.Conclusion
Preliminary data are beginning to surface that demon-
strate the efficacy of laparoscopic fertility-sparing staging
of EOC, although sample size is too small and duration of
follow-up is still too short to make definitive statements.
More research is needed to determine whether laparos-
copy affects the reproductive outcome and the oncologic
safety of this deliberately incomplete staging in this spe-
cialized population. Only the results of future data collec-
tion will provide treating oncologists and cancer patients
with valuable information to make specific decisions on
fertility-sparing options.Competing interests
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